The Oncosearch | Oncotarget

Correction: Discovery and clinical introduction of first-in-class imipridone ONC201 Correction

Joshua E. Allen, C. Leah B. Kline, Varun V. Prabhu, Jessica Wagner, Jo Ishizawa, Neel Madhukar, Avital Lev, Marie Baumeister, Lanlan Zhou, Amriti Lulla, Martin Stogniew, Lee Schalop, Cyril Benes, Howard L. Kaufman, Richard S. Pottorf, B. Rao Nallaganchu, Gary L. Olson, Fahd Al-Mulla, Madeleine Duvic, Gen Sheng Wu, David T. Dicker, Mala K. Talekar, Bora Lim, Olivier Elemento, Wolfgang Oster, Joseph Bertino, Keith Flaherty, Michael L. Wang, Gautam Borthakur, Michael Andreeff, Mark Stein, Wafik S. El-Deiry

Published Jun 22, 2021 · Vol. 12, No. 21 · pp. 2231-2231

Correction: Targeting mantle cell lymphoma metabolism and survival through simultaneous blockade of mTOR and nuclear transporter exportin-1 Correction

Kazumasa Sekihara, Kaori Saitoh, Lina Han, Stefan Ciurea, Shinichi Yamamoto, Mika Kikkawa, Saiko Kazuno, Hikari Taka, Naoko Kaga, Hajime Arai, Takashi Miida, Michael Andreeff, Marina Konopleva, Yoko Tabe

Published Oct 29, 2019 · Vol. 10, No. 63 · pp. 6842-6842

Oxidized analogs of Di(1H-indol-3-yl)methyl-4-substituted benzenes are NR4A1-dependent UPR inducers with potent and safe anti-cancer activity Research Paper

Marisa Sanchez, Zebin Xia, Elizabeth Rico-Bautista, Xihua Cao, Michael Cuddy, David J. Castro, Ricardo G. Correa, Liqun Chen, Jinghua Yu, Andrey Bobkov, Vivian Ruvolo, Michael Andreeff, Robert G. Oshima, Shu-Ichi Matsuzawa, John C. Reed, Xiao-Kun Zhang, Donna Hansel, Dieter A. Wolf, Marcia I. Dawson

Published May 18, 2018 · Vol. 9, No. 38 · pp. 25057-25074

Discovery and functional implications of a miR-29b-1/miR-29a cluster polymorphism in acute myeloid leukemia Research Paper

Apollinaire Ngankeu, Parvathi Ranganathan, Violaine Havelange, Deedra Nicolet, Stefano Volinia, Bayard L. Powell, Jonathan E. Kolitz, Geoffrey L. Uy, Richard M. Stone, Steven M. Kornblau, Michael Andreeff, Carlo M. Croce, Clara D. Bloomfield, Ramiro Garzon

Published Dec 12, 2017 · Vol. 9, No. 4 · pp. 4354-4365

Anti-leukemia activity of NSC-743380 in SULT1A1-expressing acute myeloid leukemia cells is associated with inhibitions of cFLIP expression and PI3K/AKT/mTOR activities Research Paper

Xiao Huang, Mengru Cao, Shuhong Wu, Li Wang, Jing Hu, Reza J. Mehran, Jack A. Roth, Stephen G. Swisher, Rui-Yu Wang, Hagop M. Kantarjian, Michael Andreeff, Xiaoping Sun, Bingliang Fang

Published Nov 1, 2017 · Vol. 8, No. 60 · pp. 102150-102160

Tumor Trp53 status and genotype affect the bone marrow microenvironment in acute myeloid leukemia Priority Research Paper

Rodrigo Jacamo, R. Eric Davis, Xiaoyang Ling, Sonali Sonnylal, Zhiqiang Wang, Wencai Ma, Min Zhang, Peter Ruvolo, Vivian Ruvolo, Rui-Yu Wang, Teresa McQueen, Scott Lowe, Johannes Zuber, Steven M. Kornblau, Marina Konopleva, Michael Andreeff

Published Jul 6, 2017 · Vol. 8, No. 48 · pp. 83354-83369

Targeting mantle cell lymphoma metabolism and survival through simultaneous blockade of mTOR and nuclear transporter exportin-1 Research Paper

Kazumasa Sekihara, Kaori Saitoh, Lina Han, Stefan Ciurea, Shinichi Yamamoto, Mika Kikkawa, Saiko Kazuno, Hikari Taka, Naoko Kaga, Hajime Arai, Takashi Miida, Michael Andreeff, Marina Konopleva, Yoko Tabe

Published Mar 27, 2017 · Vol. 8, No. 21 · pp. 34552-34564

IKK inhibition by BMS-345541 suppresses breast tumorigenesis and metastases by targeting GD2+ cancer stem cells Priority Research Paper

Venkata Lokesh Battula, Khoa Nguyen, Jeff Sun, Mary Kathryn Pitner, Bin Yuan, Chandra Bartholomeusz, Numsen Hail, Michael Andreeff

Published Mar 16, 2017 · Vol. 8, No. 23 · pp. 36936-36949

Discovery and clinical introduction of first-in-class imipridone ONC201 Review

Joshua E. Allen, C. Leah B. Kline, Varun V. Prabhu, Jessica Wagner, Jo Ishizawa, Neel Madhukar, Avital Lev, Marie Baumeister, Lanlan Zhou, Amriti Lulla, Martin Stogniew, Lee Schalop, Cyril Benes, Howard L. Kaufman, Richard S. Pottorf, B. Rao Nallaganchu, Gary L. Olson, Fahd Al-Mulla, Madeleine Duvic, Gen Sheng Wu, David T. Dicker, Mala K. Talekar, Bora Lim, Olivier Elemento, Wolfgang Oster, Joseph Bertino, Keith Flaherty, Michael L. Wang, Gautam Borthakur, Michael Andreeff, Mark Stein, Wafik S. El-Deiry

Published Sep 1, 2016 · Vol. 7, No. 45 · pp. 74380-74392

MLN0128, a novel mTOR kinase inhibitor, disrupts survival signaling and triggers apoptosis in AML and AML stem/ progenitor cells Research Paper

Zhihong Zeng, Rui-Yu Wang, Yi Hua Qiu, Duncan H. Mak, Kevin Coombes, Suk Young Yoo, Qi Zhang, Katti Jessen, Yi Liu, Christian Rommel, David A. Fruman, Hagop M. Kantarjian, Steven M. Kornblau, Michael Andreeff, Marina Konopleva

Published Jul 4, 2016 · Vol. 7, No. 34 · pp. 55083-55097

Biguanides sensitize leukemia cells to ABT-737-induced apoptosis by inhibiting mitochondrial electron transport Research Paper

Juliana Velez, Rongqing Pan, Jason T.C. Lee, Leonardo Enciso, Marta Suarez, Jorge Eduardo Duque, Daniel Jaramillo, Catalina Lopez, Ludis Morales, William Bornmann, Marina Konopleva, Gerald Krystal, Michael Andreeff, Ismael Samudio

Published Jun 6, 2016 · Vol. 7, No. 32 · pp. 51435-51449

Anti-apoptotic ARC protein confers chemoresistance by controlling leukemia-microenvironment interactions through a NFÎºB/IL1Î² signaling network Research Paper

Bing Z. Carter, Po Yee Mak, Ye Chen, Duncan H. Mak, Hong Mu, Rodrigo Jacamo, Vivian Ruvolo, Stefan T. Arold, John E. Ladbury, Jared K. Burks, Steven Kornblau, Michael Andreeff

Published Mar 4, 2016 · Vol. 7, No. 15 · pp. 20054-20067

Clinical implications of TP53 mutations in myelodysplastic syndromes treated with hypomethylating agents Research Paper

Koichi Takahashi, Keyur Patel, Carlos Bueso-Ramos, Jianhua Zhang, Curtis Gumbs, Elias Jabbour, Tapan Kadia, Michael Andreff, Marina Konopleva, Courtney DiNardo, Naval Daver, Jorge Cortes, Zeev Estrov, Andrew Futreal, Hagop Kantarjian, Guillermo Garcia-Manero

Published Feb 9, 2016 · Vol. 7, No. 12 · pp. 14172-14187

Synergistic effects of p53 activation via MDM2 inhibition in combination with inhibition of Bcl-2 or Bcr-Abl in CD34⁺ proliferating and quiescent chronic myeloid leukemia blast crisis cells Priority Research Paper

Bing Z. Carter, Po Yee Mak, Duncan H. Mak, Vivian R. Ruvolo, Wendy Schober, Teresa McQueen, Jorge Cortes, Hagop M. Kantarjian, Richard E. Champlin, Marina Konopleva, Michael Andreeff

Published Sep 29, 2015 · Vol. 6, No. 31 · pp. 30487-30499

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

Correction: Discovery and clinical introduction of first-in-class imipridone ONC201 Correction

Correction: Targeting mantle cell lymphoma metabolism and survival through simultaneous blockade of mTOR and nuclear transporter exportin-1 Correction

Oxidized analogs of Di(1H-indol-3-yl)methyl-4-substituted benzenes are NR4A1-dependent UPR inducers with potent and safe anti-cancer activity Research Paper

Discovery and functional implications of a miR-29b-1/miR-29a cluster polymorphism in acute myeloid leukemia Research Paper

Anti-leukemia activity of NSC-743380 in SULT1A1-expressing acute myeloid leukemia cells is associated with inhibitions of cFLIP expression and PI3K/AKT/mTOR activities Research Paper

Tumor Trp53 status and genotype affect the bone marrow microenvironment in acute myeloid leukemia Priority Research Paper

Targeting mantle cell lymphoma metabolism and survival through simultaneous blockade of mTOR and nuclear transporter exportin-1 Research Paper

IKK inhibition by BMS-345541 suppresses breast tumorigenesis and metastases by targeting GD2+ cancer stem cells Priority Research Paper

Discovery and clinical introduction of first-in-class imipridone ONC201 Review

MLN0128, a novel mTOR kinase inhibitor, disrupts survival signaling and triggers apoptosis in AML and AML stem/ progenitor cells Research Paper

Biguanides sensitize leukemia cells to ABT-737-induced apoptosis by inhibiting mitochondrial electron transport Research Paper

Anti-apoptotic ARC protein confers chemoresistance by controlling leukemia-microenvironment interactions through a NFÎºB/IL1Î² signaling network Research Paper

Clinical implications of TP53 mutations in myelodysplastic syndromes treated with hypomethylating agents Research Paper

Synergistic effects of p53 activation via MDM2 inhibition in combination with inhibition of Bcl-2 or Bcr-Abl in CD34⁺ proliferating and quiescent chronic myeloid leukemia blast crisis cells Priority Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

Correction: Discovery and clinical introduction of first-in-class imipridone ONC201 Correction

Correction: Targeting mantle cell lymphoma metabolism and survival through simultaneous blockade of mTOR and nuclear transporter exportin-1 Correction

Oxidized analogs of Di(1H-indol-3-yl)methyl-4-substituted benzenes are NR4A1-dependent UPR inducers with potent and safe anti-cancer activity Research Paper

Discovery and functional implications of a miR-29b-1/miR-29a cluster polymorphism in acute myeloid leukemia Research Paper

Anti-leukemia activity of NSC-743380 in SULT1A1-expressing acute myeloid leukemia cells is associated with inhibitions of cFLIP expression and PI3K/AKT/mTOR activities Research Paper

Tumor Trp53 status and genotype affect the bone marrow microenvironment in acute myeloid leukemia Priority Research Paper

Targeting mantle cell lymphoma metabolism and survival through simultaneous blockade of mTOR and nuclear transporter exportin-1 Research Paper

IKK inhibition by BMS-345541 suppresses breast tumorigenesis and metastases by targeting GD2+ cancer stem cells Priority Research Paper

Discovery and clinical introduction of first-in-class imipridone ONC201 Review

MLN0128, a novel mTOR kinase inhibitor, disrupts survival signaling and triggers apoptosis in AML and AML stem/ progenitor cells Research Paper

Biguanides sensitize leukemia cells to ABT-737-induced apoptosis by inhibiting mitochondrial electron transport Research Paper

Anti-apoptotic ARC protein confers chemoresistance by controlling leukemia-microenvironment interactions through a NFÎºB/IL1Î² signaling network Research Paper

Clinical implications of TP53 mutations in myelodysplastic syndromes treated with hypomethylating agents Research Paper

Synergistic effects of p53 activation via MDM2 inhibition in combination with inhibition of Bcl-2 or Bcr-Abl in CD34+ proliferating and quiescent chronic myeloid leukemia blast crisis cells Priority Research Paper

Synergistic effects of p53 activation via MDM2 inhibition in combination with inhibition of Bcl-2 or Bcr-Abl in CD34⁺ proliferating and quiescent chronic myeloid leukemia blast crisis cells Priority Research Paper